Verition Fund Management LLC Day One Biopharmaceuticals, Inc. Transaction History
Verition Fund Management LLC
- $19.9 Billion
- Q1 2025
A detailed history of Verition Fund Management LLC transactions in Day One Biopharmaceuticals, Inc. stock. As of the latest transaction made, Verition Fund Management LLC holds 27,546 shares of DAWN stock, worth $182,079. This represents 0.0% of its overall portfolio holdings.
Number of Shares
27,546
Previous 34,146
19.33%
Holding current value
$182,079
Previous $432,000
49.54%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding DAWN
# of Institutions
196Shares Held
76.7MCall Options Held
138KPut Options Held
208K-
Atlas Venture Life Science Advisors, LLC6.43MShares$42.5 Million14.93% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.94MShares$39.3 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA5.76MShares$38 Million0.95% of portfolio
-
Black Rock Inc. New York, NY4.53MShares$30 Million0.0% of portfolio
-
Alyeska Investment Group, L.P. Chicago, IL4.06MShares$26.8 Million0.14% of portfolio
About Day One Biopharmaceuticals, Inc.
- Ticker DAWN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 73,461,104
- Market Cap $486M
- Description
- Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric pa...